Manufacturer
BAXTER AG
 
Contents
Human Coagulation Factor IX-1ml of Solution contain approximately 120 IU/ml human coagulation factor IX,when reconstituted with 10ml of Sterilised Water for Injection.
 
Indication
Treatment and prophylaxis of bleeding in patients with haemophilia B (Congenital Factor IX deficiency).
 
Instruction
Treatment should be initiated and supervised by a physician experienced in the management of haemophilia.The Product should be administered via the intravenous route.
 
Drug interaction
Not known.